[1]
Shokatpour, N. et al. 2020. Daclatasvir/Sofosbuvir versus Ledipasvir/Sofosbuvir in Patients with Hepatitis C Virus Infection Genotypes 1 and 3. Novelty in Biomedicine. 8, 4 (Jun. 2020), 171–181. DOI:https://doi.org/10.22037/nbm.v1i1.29735.